Lexaria Bioscience Corp.
LEXX
$1.35
-$0.34-20.12%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.50% | -20.23% | 13.05% | 29.64% | 21.22% |
| Total Depreciation and Amortization | -46.57% | -43.12% | -41.79% | 18.29% | 29.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.08% | 50.65% | 36.93% | -15.80% | -75.74% |
| Change in Net Operating Assets | 394.09% | 121.27% | -25.63% | -298.96% | -550.95% |
| Cash from Operations | -41.71% | -11.79% | 15.68% | 13.74% | -6.10% |
| Capital Expenditure | -- | -412.12% | -27.60% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.92% | 26.39% | -7.30% | -59.76% | -73.34% |
| Cash from Investing | 20.95% | -6.70% | -11.27% | -24.02% | -27.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.60% | 263.69% | 502.73% | 502.73% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 36.99% | 275.44% | 548.88% | 499.55% | 30,733.48% |
| Foreign Exchange rate Adjustments | -373.79% | -720.45% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.04% | 337.47% | 215.39% | 236.22% | 128.17% |